Original Source(s)
Related Content
Do Systemic Alpha-2 Agonists Lower Glaucoma Risk?
A large US cohort study found systemic alpha-2 agonist use was associated with a lower hazard of glaucoma-related diagnoses vs. beta-blockers.
July 8, 2026
-
3 min
The 4-Second Blind Spot
Mike Cymbor, OD, FAAO, discusses an enduring gap in glaucoma care that could be addressed with smart contact lenses.
September 1, 2026
-
5 min
New Appointment for The Retina Clinic London
Clinic expands cataract and medical retina expertise with appointment of consultant ophthalmic surgeon
July 13, 2026
-
2 min